Are thermogenic proteins and adipokine chemerin affected by monoclonal antibody therapy in asthma?
EURASIAN JOURNAL OF PULMONOLOGY, cilt.21, sa.3, ss.161-166, 2019 (ESCI, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 21 Sayı: 3
- Basım Tarihi: 2019
- Doi Numarası: 10.4103/ejop.ejop_60_18
- Dergi Adı: EURASIAN JOURNAL OF PULMONOLOGY
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.161-166
- Yozgat Bozok Üniversitesi Adresli: Hayır
Özet
BACKGROUND: Irisin is a thermogenic protein that sources outgoing energy by converting white adipose tissue to brown adipose tissue. Chemerin is originally identified as a chemoattractant protein that mainly mediating the chemotaxis of dendritic cells and natural killer cells (NKCs). The aim of this study is to assess the potential impact of immune modulation-related chemerin and irisin concentrations together with cell surface markers (CSM) in allergic asthmatic patients under omalizumab treatment.